Mobile

A Clinical trial to compare standard of care treatment: Nab-Paclitaxel/Gemcitabine alone or in combination with ACP-196 in patients with previously untreated Metastatic Pancreatic Cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-003428-30

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of ACP-196 and nab-paclitaxel/gemcitabine based on ORR in subjects with metastatic pancreatic cancer using standard response criteria

Critère d'inclusion

  • Metastatic Pancreatic Cancer

Liens